ClinicalTrials.govpublic full text
Study to Evaluate Immunogenicity and Safety of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine at 9 and 10 Years After Vaccine Administration and Assessment of Re-vaccination With 2 Additional Doses at 10 Years After Initial Vaccination, in Healthy Subjects Aged 60 Years of Age(YOA) and Older
herpes zoster
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 459958
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.